Core Viewpoint - The collaboration between Betaini and Tripollar (Chupu) aims to create a "medical + beauty" home skincare system, addressing both companies' needs for growth and reliable operations [1][3][8]. Group 1: Collaboration Details - Betaini is forming a professional operations team for Tripollar, with an announcement expected soon [1]. - The partnership is seen as mutually beneficial, with Betaini seeking new growth avenues and Tripollar needing a credible operator to regain market presence [1][4]. - The collaboration is described as a "comprehensive strategic partnership," with Betaini leveraging Tripollar's brand to enhance its offerings in the medical beauty sector [3]. Group 2: Market Context - Tripollar entered the Chinese market in 2014 and gained significant recognition by 2019, achieving nearly 1 billion yuan in GMV in 2020 [4]. - Betaini has faced declining revenues and profits, with net profit dropping over 80% in Q1 2025, indicating a need for new strategies to overcome stagnation [5][6]. - The home RF beauty device market is under stricter regulations, requiring Tripollar to obtain Class III medical device certification by April 2026, which it has not yet secured [7][11]. Group 3: Industry Trends - The collaboration reflects a broader trend in the beauty industry where brands are integrating medical technology into their product lines, as seen with other companies like Marubi and L'Oreal [9]. - Betaini's strategy includes expanding into the home beauty device market, which aligns with the growing demand for medical and semi-medical beauty products [9][10]. - The partnership may help Betaini quickly enter the home beauty device market by utilizing Tripollar's existing brand recognition, thus saving on market education and promotion costs [10].